Chemoinformaics analysis of 3-METHYL-2-PENTYLCYCLOPENT-2-EN-1-ONE
Molecular Weight | 166.264 | nRot | 4 |
Heavy Atom Molecular Weight | 148.12 | nRig | 12 |
Exact Molecular Weight | 166.136 | nRing | 1 |
Solubility: LogS | -3.202 | nHRing | 0 |
Solubility: LogP | 1.721 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 31.1743 |
nHD | 0 | BPOL | 18.9257 |
QED | 0.666 |
Synth | 3.538 |
Natural Product Likeliness | -1.681 |
NR-PPAR-gamma | 0.115 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.043 |
Pgp-sub | 0.025 |
HIA | 0.014 |
CACO-2 | -4.822 |
MDCK | 0.0000457 |
BBB | 0.741 |
PPB | 0.329901 |
VDSS | 0.895 |
FU | 0.728107 |
CYP1A2-inh | 0.993 |
CYP1A2-sub | 0.973 |
CYP2c19-inh | 0.942 |
CYP2c19-sub | 0.082 |
CYP2c9-inh | 0.674 |
CYP2c9-sub | 0.469 |
CYP2d6-inh | 0.122 |
CYP2d6-sub | 0.722 |
CYP3a4-inh | 0.22 |
CYP3a4-sub | 0.316 |
CL | 4.941 |
T12 | 0.375 |
hERG | 0.032 |
Ames | 0.998 |
ROA | 0.248 |
SkinSen | 0.218 |
Carcinogencity | 0.978 |
EI | 0.075 |
Respiratory | 0.971 |
NR-Aromatase | 0.049 |
Antiviral | No |
Prediction | 0.800432 |